Trade Mark Journal No.2026/010 6 March 2026
WO0000001902777 (9,10)
Office of origin: United States of America
Date of International Registration:14 January 2026
Date of designation in the UK:
14 January 2026

International priority date claimed: 17 July 2025
(United States of America)
(99289673)
- Class 9
- Downloadable computer software for monitoring blood glucose and managing diabetes; downloadable computer software for mobile phones, namely, software for monitoring blood glucose and managing diabetes.
- Class 10
- Medical products, namely, biofeedback sensors; medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; glucose meters; wearable monitors used to measure biometric data for medical use.
Biolinq Incorporated
Representative: John Paul Oleksiuk Cooley LLP, 1299 Pennsylvania Ave., NW, Washington DC 20004, UNITED STATES OF AMERICA